Amerikaanse aandelen « Terug naar discussie overzicht

Phunware Inc.

19.112 Posts, Pagina: « 1 2 3 4 5 6 ... 740 741 742 743 744 745 746 747 748 749 750 ... 952 953 954 955 956 » | Laatste

Omlaag ↓

Jager63 21 april 2022 18:12

Compleet slagveld in mijn porto!

Jager63 21 april 2022 20:57

www.benzinga.com/trading-ideas/techni...

CAMBER

Jager63 22 april 2022 07:14

Pharming announces change in its holding in BioConnection following a substantial investment by new
investor

Following an agreed investment by European investment company Gimv, Pharming's minority stake of 43.85% in BioConnection will reduce to 22.98%. As a result of this transaction, Pharming will receive one-off US$ 7.5 million (EUR 6.9 million) net cash proceeds. Pharming continues to support BioConnection to accelerate its growth strategy together with Gimv and its other shareholders.
Leiden, The Netherlands, 22 April 2022
Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM/NASDAQ: PHAR) announces a change in its minority holding in BioConnection B.V, a contract development and manufacturing organization (CDMO) and the long-time fill and finish partner in the production of Pharming's product RUCONEST®. In April 2019, the company announced it had invested €4.1 million to acquire a 43.85% stake in BioConnection through its 100% subsidiary Pharming Technologies B.V.

Following receipt of an offer for all shares in BioConnection by Gimv, a European investment company listed on Euronext Brussels, the existing shareholders (including Pharming) reached agreement with Gimv today on the sale of all issued and outstanding shares to a new holding company incorporated by Gimv for BioConnection, followed by a partial re-investment by existing shareholders of the purchase price in the share capital of that new holding company.

As a result of the transaction, the minority stake held by Pharming in BioConnection will reduce to 22.98% and Pharming will receive one-off US$ 7.5 million (EUR 6.9 million) net cash proceeds in Q2 2022.

Chief Executive Officer, Sijmen de Vries, commented:
"We are pleased to continue our investment into BioConnection, as they have been an excellent partner for Pharming for many years. We look forward to continuing to support BioConnection as it continues to grow, and to work with existing shareholders and welcome Gimv as a new shareholder in BioConnection."

About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming is headquartered in Leiden, Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific. For more information, visit www.pharming.com.

Forward-looking Statements
This press release contains forward-looking statements, including with respect to timing and progress of Pharming's preclinical studies and clinical trials of its product candidates, Pharming's clinical and commercial prospects, Pharming's ability to overcome the challenges posed by the COVID-19 pandemic to the conduct of its business, and Pharming's expectations regarding its projected working capital requirements and cash resources, which statements are subject to a number of risks, uncertainties and assumptions, including, but not limited to the scope, progress and expansion of Pharming's clinical trials and ramifications for the cost thereof; and clinical, scientific, regulatory and technical developments. In light of these risks and uncertainties, and other risks and uncertainties that are described in Pharming's 2021 Annual Report and the Annual Report on Form 20-F for the year ended December 31, 2021 filed with the U.S. Securities and Exchange Commission, the events and circumstances discussed in such forward-looking statements may not occur, and Pharming's actual results could differ materially and adversely from those anticipated or implied thereby. Any forward-looking statements speak only as of the date of this press release and are based on information available to Pharming as of the date of this release.

Inside Information
This press release relates to the disclosure of information that qualifies, or may have qualified, as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.

For further public information, contact:
Pharming Group, Leiden, The Netherlands
Sijmen de Vries, CEO
T: +31 71 524 7400

FTI Consulting, London, UK:
Victoria Foster Mitchell / Alex Shaw
T: +44 203 727 100

FTI Consulting, USA
Jim Polson
T: +1 (312) 553-6730

LifeSpring Life Sciences Communication, Amsterdam, The Netherlands:
Leon Melens
T: +31 6 53 81 64 27
E-Mail: pharming@lifespring.nl

Jager63 22 april 2022 07:25

investorplace.com/2022/04/the-future-...

GEVO

Jager63 22 april 2022 07:26

www.marketwatch.com/press-release/gev...

GEVO

Jager63 22 april 2022 10:30

Mijn strategie tussen rood en dieprood heb ik nog steeds niet onder de knie.

Verschil vaak vele procenten!

Jager63 22 april 2022 18:52

Hier word ik zelfs stil van!

The Pigeonman 22 april 2022 21:28

quote:
Jager63 schreef op 22 april 2022 18:52:
Hier word ik zelfs stil van!

Wel wat groens in de portefeuille maar overall is het een ramp! :-(

Jager63 22 april 2022 22:24

Alleen geduld kan ons nog redden!

Jager63 23 april 2022 09:24

investorplace.com/2022/04/cei-stock-b...

CAMBER

Jager63 23 april 2022 09:26

www.marketwatch.com/press-release/inv...

GEVO

Jager63 23 april 2022 13:15

www.sec.gov/Archives/edgar/data/13923...

GEVO

Jager63 24 april 2022 07:08

quote:
Jager63 schreef op 23 april 2022 09:26:
www.marketwatch.com/press-release/inv...

GEVO

Press Release
INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Gevo, Inc. for Potential Breach of Fiduciary Duty Claims
Published: April 22, 2022 at 7:12 a.m. ET

Dit zit me niet lekker.

Iemand enig idee?

The Pigeonman 24 april 2022 13:41

quote:
Jager63 schreef op 24 april 2022 07:08:
[...]
Press Release
INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Gevo, Inc. for Potential Breach of Fiduciary Duty Claims
Published: April 22, 2022 at 7:12 a.m. ET

Dit zit me niet lekker.

Iemand enig idee?

Geen idee Jan maar wil me wel verdiepen. Dat wordt dan vanavond pas!

Jager63 24 april 2022 14:08

quote:
The Pigeonman schreef op 24 april 2022 13:41:
[...]

Geen idee Jan maar wil me wel verdiepen. Dat wordt dan vanavond pas!

Bedankt alvast Nol.

The Pigeonman 24 april 2022 15:19

Ik kom er niet ver mee Jan. Mijn vertaalsite blokkeert. Gaan de Russen er zich mee bemoeien?

Jager63 24 april 2022 17:35

quote:
The Pigeonman schreef op 24 april 2022 15:19:
Ik kom er niet ver mee Jan. Mijn vertaalsite blokkeert. Gaan de Russen er zich mee bemoeien?

Komt er op neer dat ze de administratie/gang van zaken bij GEVO gaan doorlichten. Hopelijk komen er geen verrassingen boven water.

Raad van bestuur staat onder verdenking. Verder kan ik niets vinden. Morgen hopelijk wat duidelijkheid.
Dus waar het precies over gaat!

Jager63 24 april 2022 17:51

Blijkbaar is de Raad van Bestuur wat slordig omgegaan met het geld van derden.

Tot zover mijn eigen vertaling en interpretatie.

Jager63 24 april 2022 18:15

investors.gevo.com/news/gevo-to-repor...

Dit bericht zat vorige week nog in mijn mailbox.

Heb in afwachting van de cijfers flink bijgekocht. Zal morgen wel flink inleveren worden.

GEVO laat je tanden zien!!!

Jager63 25 april 2022 06:52

Gek genoeg is Gevo nog steeds een van de weinige aandelen die me een hoog rendement hebben opgeleverd.
Dus veel meer dan voor wat ik er nu nog inzit.

19.112 Posts, Pagina: « 1 2 3 4 5 6 ... 740 741 742 743 744 745 746 747 748 749 750 ... 952 953 954 955 956 » | Laatste

Aantal posts per pagina: 20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Markt vandaag

AEX 910,88 +7,27 +0,80% 14:23


Germany40^	18.642,20	+0,78%
BEL 20	3.935,06	+0,43%
EURO50	5.021,81	+0,21%
US30^	38.701,50	0,00%
Nasd100^	18.650,30	+0,60%
US500^	5.295,74	+0,29%
Japan225^	38.828,60	+0,51%
Gold spot	2.328,67	+0,05%
EUR/USD	1,0846	-0,02%
WTI	77,15	+0,01%